ArticleInternational journal of molecular sciences2018

Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles.

Yu Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.